Explication of the roles of prostate health index (PHI) and urokinase plasminogen activator (uPA) as diagnostic and predictor tools for prostate cancer in equivocal PSA range of 4–10 ng/mL

BACKGROUND: Prostate cancer (PCa) is one of the most commonly encountered cancers and the leading cause of death worldwide. Currently used biomarkers accounts difficulties in discriminating benign from malignant cases or predicting outcome, so investigating new biomarkers performance is needed. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassir, Anmar M., Kamel, Hala F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376136/
https://www.ncbi.nlm.nih.gov/pubmed/32714021
http://dx.doi.org/10.1016/j.sjbs.2020.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376136/
https://www.ncbi.nlm.nih.gov/pubmed/32714021
http://dx.doi.org/10.1016/j.sjbs.2020.04.004

Ejemplares similares